Beta cyclodextrin conjugated Au Fe3O4 Janus nanoparticles with enhanced chemo-photothermal therapy performance
Acta Biomaterialia · 2024
DOI: 10.1016/j.actbio.2024.05.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2024. Verfasst von Sumin Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Industry 4.0 Convergence Bionics Engineering, Pukyong National University, Busan 48513, Republic of Korea. Hauptthemen laut MEDLINE: Gold, beta-Cyclodextrins, Mice, Nude. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
The strategic integration of multi-functionalities within a singular nanoplatform has received growing attention for enhancing treatment efficacy, particularly in chemo-photothermal therapy. This study introduces a comprehensive concept of Janus nanoparticles (JNPs) composed of Au and Fe3O4 nanostructures intricately bonded with β-cyclodextrins (β-CD) to encapsulate 5-Fluorouracil (5-FU) and Ibuprofen (IBU). This strategic structure is engineered to exploit the synergistic effects of chemo-photothermal therapy, underscored by their exceptional biocompatibility and photothermal conversion efficiency (∼32.88 %). Furthermore, these β-CD-conjugated JNPs enhance photodynamic therapy by generating singlet oxygen (1O2) species, offering a multi-modality approach to cancer eradication. Computer simulation results were in good agreement with in vitro and in vivo assays. Through these studies, we were able to prove the improved tumor ablation ability of the drug-loaded β-CD-conjugated JNPs, without inducing adverse effects in tumor-bearing nude mice. The findings underscore a formidable tumor ablation potency of β-CD-conjugated Au-Fe3O4 JNPs, heralding a new era in achieving nuanced, highly effective, and side-effect-free cancer treatment modalities. STATEMENT OF SIGNIFICANCE: The emergence of multifunctional nanoparticles marks a pivotal stride in cancer therapy research. This investigation unveils Janus nanoparticles (JNPs) amalgamating gold (Au), iron oxide (Fe3O4), and β-cyclodextrins (β-CD), encapsulating 5-Fluorouracil (5-FU) and Ibuprofen (IBU) for synergistic chemo-photothermal therapy. Demonstrating both biocompatibility and potent photothermal properties (∼32.88 %), these JNPs present a promising avenue for cancer treatment. Noteworthy is their heightened photodynamic efficiency and remarkable tumor ablation capabilities observed in vitro and in vivo, devoid of adverse effects. Furthermore, computational simulations validate their interactions with cancer cells, bolstering their utility as an emerging therapeutic modality. This endeavor pioneers a secure and efficacious strategy for cancer therapy, underscoring the significance of β-CD-conjugated Au-Fe3O4 JNPs as innovative nanoplatforms with profound implications for the advancement of cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Industry 4.0 Convergence Bionics Engineering, Pukyong National University, Busan 48513, Republic of Korea.
- Smart Gym-Based Translational Research Center for Active Senior's Healthcare, Pukyong National University, Busan 48513, Republic of Korea.
- Digital Healthcare Research Center, Pukyong National University, Busan 48513, Republic of Korea.
- Institute of Physics, Autonomous University of Puebla, Puebla 72570, Mexico.
- Industry 4.0 Convergence Bionics Engineering, Pukyong National University, Busan 48513, Republic of Korea; Smart Gym-Based Translational Research Center for Active Senior's Healthcare, Pukyong National University, Busan…
Förderung
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Park, S., Choi, J., Ko, N., Mondal, S., Pal, U., Lee, B. I., & Oh, J. (2024). Beta cyclodextrin conjugated Au Fe3O4 Janus nanoparticles with enhanced chemo-photothermal therapy performance. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2024.05.008
Vancouver
Park S, Choi J, Ko N, Mondal S, Pal U, Lee BI, et al. Beta cyclodextrin conjugated Au Fe3O4 Janus nanoparticles with enhanced chemo-photothermal therapy performance. Acta Biomaterialia. 2024. doi:10.1016/j.actbio.2024.05.008
BibTeX
@article{Park2024,
author = {Park, Sumin and Choi, Jaeyeop and Ko, Namsuk and Mondal, Sudip and Pal, Umapada and Lee, Byeong-Il and Oh, Junghwan},
title = {Beta cyclodextrin conjugated Au Fe3O4 Janus nanoparticles with enhanced chemo-photothermal therapy performance},
journal = {Acta Biomaterialia},
year = {2024},
doi = {10.1016/j.actbio.2024.05.008}
}
EUVIMED